AI assistant
Sending…
TransMedics Group, Inc. — Director's Dealing 2020
Apr 24, 2020
31201_dirs_2020-04-24_f5cdd4a7-98ca-4bcd-a027-1a57e993df4f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2020-04-22
Reporting Person: Gordon Stephen (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-04-22 | Common Stock | S | 100 | $18.00 | Disposed | 28471 | Direct |
Footnotes
F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.
More from TransMedics Group, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 21
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Feb 27
Annual Report
2026
Feb 24
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 20